Decision details

To utilise the right to extend the term of the Social Prescribing Innovation Partnership contract for 1 year until 31st March 2024, including continuing the offer for children developed over the last year.

RESOLVED - That: The proposals outlined in the report are agreed; the Social Prescribing Innovation Partnership contract is extended for 1 year until 31st March 2024. This will be at a total cost of £605,614.

Option 1 – The proposals outlined in the report are agreed; the Social Prescribing Innovation Partnership contract is extended for 1 year until 31st March 2024. This will be at a total cost of £605,614.
Option 2 - It is agreed not to extend the Social Prescribing contract. This option would have no direct cost to Oldham system partners however, if delivery were to cease this would have the knock-on impact of the current Social Prescribing caseload and those in triage, at total of 600+ people, potentially being left without support and needing additional services from the wider system. It would have associated impacts for the Innovation Partnership providers who would either need to seek alternative funding in a short timescale or cease delivery putting existing staff at risk.

Option 2 - It is agreed not to extend the Social Prescribing contract. This option would have no direct cost to Oldham system partners however, if delivery were to cease this would have the knock-on impact of the current Social Prescribing caseload and those in triage, at total of 600+ people, potentially being left without support and needing additional services from the wider system. It would have associated impacts for the Innovation Partnership providers who would either need to seek alternative funding in a short timescale or cease delivery putting existing staff at risk.

Consultation has taken place with the lead provider of the Social Prescribing Innovation Partnership and GM ICP.